| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 436.9 | 329.7 | 306.2 |
| Other income | 5.1 | 1.8 | 9.8 |
| Total income | 442.0 | 331.5 | 316.0 |
| Profit before exceptional items & tax | 167.4 | 103.9 | 96.2 |
| Profit before tax | 167.4 | 103.9 | 96.2 |
| Net profit | 123.1 | 75.0 | 71.9 |
| Operating margin | 37.9% | 31.3% | 30.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +71.20% |
|---|---|
| Net profit, quarter on quarter | +64.10% |
| Revenue, year on year | +42.70% |
| Operating profit, year on year | +87.80% |
| Operating profit, quarter on quarter | +59.00% |
BSE results filing, NSE: ACUTAAS. Figures extracted from the filing.
Acutaas Chemicals Ltd: key numbers
- Share price
- ₹3,710.00
- Market cap
- ₹30,374 Cr
- Revenue (annual)
- ₹1,339 Cr
- Net profit (annual)
- ₹356.3 Cr
- P/E (TTM)
- 69.2×Sector 46.1×
- Promoter holding
- 32.66%+0.00% QoQ
- FII holding
- 22.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Acutaas Chemicals Ltd
All →Acutaas Chemicals Earnings Call Transcript: Key Takeaways
Acutaas reports high-growth Q2 fueled by pharma intermediates and CDMO scaling, despite commodity chemical phase-outs.
- Call
- Guides 100% growth
Acutaas Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹4,369 Mn (+42.7% YoY), EBITDA ₹1,760 Mn (+84.6%, 40.3% margin), PAT ₹1,231 Mn (+71.4%). FY27 revenue guidance raised; South Korea semiconductor-chemicals facility inaugurated.
- Call
- Guides 30% growth
Acutaas Chemicals Results Update
Q2 FY27 revenue rose 42.7% YoY to ₹4,369 mn; PAT up 71.4% to ₹1,231 mn. Guidance raised to 30% revenue growth and 38-40% EBITDA margin.
Acutaas Chemicals Financial Results
Acutaas Chemicals' board approved Q2 and half-year FY2027 unaudited results. The board meeting closed with no other material transaction disclosed.
Acutaas Chemicals Board Meeting Date
Acutaas Chemicals scheduled its board meeting for October 27, 2026, to approve Q2 and H1 FY27 unaudited results. No financial figures or decisions are reported, only the meeting date and agenda.
Acutaas Chemicals Merger & Restructuring Worth ₹0.01 Cr
Acutaas Chemicals completed the acquisition of Enchem Ami Organics, making it a wholly owned subsidiary. This share transfer transaction was completed for ₹0.01 Crore.
- Value
- ₹0.01 Cr